Form 8-K - Current report:
SEC Accession No. 0000914475-24-000206
Filing Date
2024-10-11
Accepted
2024-10-11 16:02:22
Documents
14
Period of Report
2024-10-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K nbix-20241011.htm   iXBRL 8-K 27421
5 GRAPHIC nbix-20241011_g1.jpg GRAPHIC 18386
  Complete submission text file 0000914475-24-000206.txt   201734

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nbix-20241011.xsd EX-101.SCH 1910
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nbix-20241011_lab.xml EX-101.LAB 21629
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nbix-20241011_pre.xml EX-101.PRE 12514
16 EXTRACTED XBRL INSTANCE DOCUMENT nbix-20241011_htm.xml XML 2716
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 6027 EDGEWOOD BEND COURT SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filer) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22705 | Film No.: 241367550
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)